Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke

Joan Martí-Fàbregas¹, Daniel Guisado-Alonso¹, Raquel Delgado-Mederos¹, Alejandro Martínez-Domeño¹, Luis Prats-Sánchez¹, Marina Guasch-Jiménez¹, Pere Cardona², Ana Núñez-Guillén², Manuel Requena³, Marta Rubiera³, Marta Olivé³, Alejandro Bustamante⁴, Meritxell Gomis⁴, Sergio Amaro⁵, Laura Llull⁵, Xavier Ustrell⁶, Gislaine Castilho de Oliveira⁶, Laia Seró⁶, Manuel Gomez-Choco⁷, Luis Mena⁷, Joaquín Serena⁸, Saima Bashir Viturro⁸, Francisco Purroy⁹, Mikel Vicente⁹, Ana Rodríguez-Campello¹⁰, Angel Ois¹⁰, Esther Catena¹¹, Maria Carmen Garcia-Carreira¹², Oriol Barrachina¹², Ernest Palomeras¹³, Jerzky Krupinski¹⁴, Marta Almeria¹⁴, Josep Zaragoza¹⁵, Patricia Esteve¹⁵, Dolores Cocho¹⁶, Antia Moreira^{10

17}, Cecile van Eendenburg¹⁸, Javier Emilio Codas¹⁹, Natalia Pérez de la Ossa²⁰, Mercè Salvat²⁰, Pol Camps-Renom¹; COVICTUS Collaborators

Affiliations

¹ Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (J.M.-F., D.G.-A., R.D.-M., A.M.-D., L.P.-S., M.G.-J., P.C.-R.).
² Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Spain (P.C., A.N.-G.).
³ Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain (M. Requena, M. Rubiera, M.O.).
⁴ Department of Neurology, Hospital Germans Trias i Pujol, Badalona, Spain (A.B., M.G.).
⁵ Department of Neurology, Hospital Universitari Clinic, Barcelona, Spain (S.A., L.L.).
⁶ Department of Neurology, Hospital Universitari Joan XXIII, Tarragona, Spain (X.U., G.C.d.O., L.S.).
⁷ Department of Neurology, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain (M.G.-C., L.M.).
⁸ Department of Neurology, Hospital Universitari Dr. Josep Trueta, Girona, Spain (J.S., S.B.V.).
⁹ Stroke Unit, Hospital Universitari Arnau de Vilanova, Lleida, Spain (F.P., M.V.).
¹⁰ Department of Neurology, Hospital del Mar, Barcelona, Spain (A.R.-C., A.O., A.M.).
¹¹ Department of Neurology, Hospital comarcal de l'Alt Penedès, Vilafranca del Penedès, Spain (E.C.).
¹² Department of Neurology, Hospital Universitari Parc Taulí, Sabadell, Spain (M.C.G.-C., O.B.).
¹³ Department of Neurology, Hospital de Mataró, Spain (E.P.).
¹⁴ Department of Neurology, Hospital Universitari Mútua de Terrassa, Spain (J.K., M.A.).
¹⁵ Department of Neurology, Hospital de Tortosa Verge de la Cinta, Spain (J.Z., P.E.).
¹⁶ Department of Neurology, Hospital General de Granollers, Spain (D.C.).
¹⁷ Department of Neurology, Hospital d'Igualada, Spain (A.M.).
¹⁸ Department of Neurology, Hospital de Figueres, Spain (C.v.E.).
¹⁹ Department of Neurology, Consorci Sanitari de Terrassa, Spain (J.E.C.).
²⁰ Stroke Program, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain (N.P.d.l.O., M.S.).

PMID: 34455823
PMCID: PMC8607902
DOI: 10.1161/STROKEAHA.121.034883

Observational Study

Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke

Joan Martí-Fàbregas et al. Stroke. 2021 Dec.

. 2021 Dec;52(12):3908-3917.

doi: 10.1161/STROKEAHA.121.034883. Epub 2021 Aug 30.

Authors

Affiliations

¹ Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (J.M.-F., D.G.-A., R.D.-M., A.M.-D., L.P.-S., M.G.-J., P.C.-R.).
² Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Spain (P.C., A.N.-G.).
³ Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain (M. Requena, M. Rubiera, M.O.).
⁴ Department of Neurology, Hospital Germans Trias i Pujol, Badalona, Spain (A.B., M.G.).
⁵ Department of Neurology, Hospital Universitari Clinic, Barcelona, Spain (S.A., L.L.).
⁶ Department of Neurology, Hospital Universitari Joan XXIII, Tarragona, Spain (X.U., G.C.d.O., L.S.).
⁷ Department of Neurology, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain (M.G.-C., L.M.).
⁸ Department of Neurology, Hospital Universitari Dr. Josep Trueta, Girona, Spain (J.S., S.B.V.).
⁹ Stroke Unit, Hospital Universitari Arnau de Vilanova, Lleida, Spain (F.P., M.V.).
¹⁰ Department of Neurology, Hospital del Mar, Barcelona, Spain (A.R.-C., A.O., A.M.).
¹¹ Department of Neurology, Hospital comarcal de l'Alt Penedès, Vilafranca del Penedès, Spain (E.C.).
¹² Department of Neurology, Hospital Universitari Parc Taulí, Sabadell, Spain (M.C.G.-C., O.B.).
¹³ Department of Neurology, Hospital de Mataró, Spain (E.P.).
¹⁴ Department of Neurology, Hospital Universitari Mútua de Terrassa, Spain (J.K., M.A.).
¹⁵ Department of Neurology, Hospital de Tortosa Verge de la Cinta, Spain (J.Z., P.E.).
¹⁶ Department of Neurology, Hospital General de Granollers, Spain (D.C.).
¹⁷ Department of Neurology, Hospital d'Igualada, Spain (A.M.).
¹⁸ Department of Neurology, Hospital de Figueres, Spain (C.v.E.).
¹⁹ Department of Neurology, Consorci Sanitari de Terrassa, Spain (J.E.C.).
²⁰ Stroke Program, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain (N.P.d.l.O., M.S.).

PMID: 34455823
PMCID: PMC8607902
DOI: 10.1161/STROKEAHA.121.034883

Abstract

Background and purpose: We evaluated whether stroke severity, functional outcome, and mortality are different in patients with ischemic stroke with or without coronavirus disease 2019 (COVID-19) infection.

Methods: A prospective, observational, multicentre cohort study in Catalonia, Spain. Recruitment was consecutive from mid-March to mid-May 2020. Patients had an acute ischemic stroke within 48 hours and a previous modified Rankin Scale (mRS) score of 0 to 3. We collected demographic data, vascular risk factors, prior mRS score, National Institutes of Health Stroke Scale score, rate of reperfusion therapies, logistics, and metrics. Primary end point was functional outcome at 3 months. Favourable outcome was defined depending on the previous mRS score. Secondary outcome was mortality at 3 months. We performed mRS shift and multivariable analyses.

Results: We evaluated 701 patients (mean age 72.3±13.3 years, 60.5% men) and 91 (13%) had COVID-19 infection. Median baseline National Institutes of Health Stroke Scale score was higher in patients with COVID-19 compared with patients without COVID-19 (8 [3-18] versus 6 [2-14], P=0.049). Proportion of patients with a favourable functional outcome was 33.7% in the COVID-19 and 47% in the non-COVID-19 group. However, after a multivariable logistic regression analysis, COVID-19 infection did not increase the probability of unfavourable functional outcome. Mortality rate was 39.3% among patients with COVID-19 and 16.1% in the non-COVID-19 group. In the multivariable logistic regression analysis, COVID-19 infection was a risk factor for mortality (hazard ratio, 3.14 [95% CI, 2.10-4.71]; P<0.001).

Conclusions: Patients with ischemic stroke and COVID-19 infection have more severe strokes and a higher mortality than patients with stroke without COVID-19 infection. However, functional outcome is comparable in both groups.

Keywords: cerebrovascular disease; coronavirus; pandemics; prognosis; reperfusion; stroke; thrombectomy.

PubMed Disclaimer

Figures

**Figure 1.**
Scores on the modified Rankin Scale at 3 mo according to the coronavirus disease 2019 (COVID-19) infection status.

**Figure 2.**
Kaplan-Meier survival curve for mortality at 3 mo according to the coronavirus disease 2019 (COVID-19) infection status.

See this image and copyright information in PMC

References

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a report of 72 314 cases Ffrom the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648 - PubMed
1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, et al. ; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059. doi: 10.1001/jama.2020.6775 - PMC - PubMed
1. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, et al. . Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–1770. doi: 10.1016/S0140-6736(20)31189-2 - PMC - PubMed
1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:1–9. doi: 10.1001/jamaneurol.2020.1127 - PMC - PubMed
1. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, González E, Redondo-Peñas I, Perona-Moratalla AB, Del Valle-Pérez JA, et al. . Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95:e1060–e1070. doi: 10.1212/WNL.0000000000009937 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke

Affiliations

Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke

Authors

Affiliations

Abstract

Figures

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical